Fondaparinux in Acute Coronary Syndromes

PRODUCT LITERATURE

Fondaparinux in Acute Coronary Syndromes

Trailokya A - Personal Name;

Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Anticoagulant-associated adverse events like heparin-induced thrombocytopenia, bleeding complications and need of close monitoring of anticoagulation led to focus on developing agents causing anticoagulation without affecting primary haemostasis.
Fondaparinux, a new-age synthetic anticoagulant, acts by inhibiting
factor Xa. It is simple to administer and has low inter and intra-subject
variability.

Availability

Titan Center Location name is not set

Diviti-001

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: -
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Diviti
Specific Detail Info: Journal of The Association of Physicians of India ■ Vol. 63 ■ July 2015
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment